Condition
Orgasmic Disorder
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 2 (2)
Trial Status
Completed3
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06516055Phase 2Not Yet RecruitingPrimary
Study of S1B-408 in Women With Orgasmic Dysfunction
NCT04824820Not ApplicableCompleted
Improving Female Sexual Wellness
NCT04566783Completed
Identification of Etiopathological and Clinical Factors in Persistent Genital Arousal Disorder
NCT00248209Phase 2CompletedPrimary
Female Orgasmic Disorder (FOD) and Wellbutrin XL
Showing all 4 trials